You are here

  • Home
  • Archive
  • Volume 5, Issue Suppl 2
  • CT-04 Safety and efficacy of allogeneic umbilical cord-derived mesenchymal stem cells (MSCs) in patients with systemic lupus erythematosus: results of an open-label phase I study

Citation Tools

Article menu

Download PDFPDF

Clinical Trials
CT-04 Safety and efficacy of allogeneic umbilical cord-derived mesenchymal stem cells (MSCs) in patients with systemic lupus erythematosus: results of an open-label phase I study
Free

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Kamen DL, Nietert PJ, Wang H, et al
CT-04 Safety and efficacy of allogeneic umbilical cord-derived mesenchymal stem cells (MSCs) in patients with systemic lupus erythematosus: results of an open-label phase I study
Lupus Science & Medicine 2018;5:doi: 10.1136/lupus-2018-lsm.76